Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
2.020
+0.410 (25.47%)
At close: Mar 6, 2026, 4:00 PM EST
2.000
-0.020 (-0.99%)
After-hours: Mar 6, 2026, 7:59 PM EST
Pulmonx Market Cap
Pulmonx has a market cap or net worth of $83.32 million as of March 6, 2026. Its market cap has decreased by -75.97% in one year.
Market Cap
83.32M
Enterprise Value
69.93M
1-Year Change
-75.97%
Ranking
Category
Stock Price
$2.02
Market Cap Chart
Since the IPO on October 1, 2020, Pulmonx's market cap has decreased from $1.33B to $83.32M, a decrease of -93.75%. That is a compound annual growth rate of -39.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 83.32M | -8.60% |
| Dec 31, 2025 | 91.16M | -66.00% |
| Dec 31, 2024 | 268.12M | -45.11% |
| Dec 29, 2023 | 488.43M | 54.88% |
| Dec 30, 2022 | 315.36M | -73.31% |
| Dec 31, 2021 | 1.18B | -52.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Baird Medical Investment Holdings | 113.85M |
| Hyperfine | 103.97M |
| Neuronetics | 94.51M |
| Treace Medical Concepts | 92.13M |
| Xtant Medical Holdings | 86.80M |
| MaxCyte | 83.46M |
| Picard Medical | 79.60M |
| Sera Prognostics | 74.49M |